Data_Sheet_1_The Heme Transporter HtsABC of Group A Streptococcus Contributes to Virulence and Innate Immune Evasion in Murine Skin Infections.DOCX by Yingli Song (5283008)

“…The htsA deletion also decreased the GAS adhesion rate to Hep-2 cells, the survival in human blood and rat neutrophils, and increased the production of cytokine IL-1β, IL-6, and TNF-α levels in air pouch exudate of a mouse model of subcutaneous infection. …”

Restitution of p120ctn-1A or p120ctn-3A in p120ctn depleted A549 cells could restore cyclin D1 and cyclin E. by Guiyang Jiang (164288)

“…(<b>B</b> and <b>C</b>) The results of MTT and flow cytometry showed that cell proliferation was effectively restored (<i>p</i><0.01), G₁ phase cells were significantly decreased (*, <i>p</i> = 0.001, **, <i>p</i> = 0.004) and S phase cells were significantly increased (*, <i>p</i> = 0.004, **, <i>p</i> = 0.028) after p120ctn depleted A549 cells were transfected with p120ctn-1A or 3A. …”

Kavain did not affect propofol potentiation, but modestly reduced propofol activation at α1β2γ2L GABA_ARs. by Han Chow Chua (817600)

DataSheet_1_Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study.pdf by Qian Yang (300330)

“…Conversely, higher levels of the triglyceride to HDL (TG/HDL) ratio (OR, 0.90; 95% CI, 0.84-0.98), total cholesterol to HDL (Chol/HDL) ratio (OR, 0.77; 95% CI, 0.64-0.92), and low-density lipoprotein to HDL (LDL/HDL) ratio (OR, 0.85; 95% CI, 0.76-0.96) were associated with a decreased likelihood of seroprotection.</p>Conclusion<p>This study suggests that lipid levels may play a role in modulating the immune response following HBV vaccination.…”

MCF-7 cells were treated with 0, 10, or 20 μM of Peptide 1 or Peptide 2 for 48h. by Deepu Dowarha (5673440)

Subjects:

S100A1 complete sequence indicating highlighted region selected for peptide construction, attaching it to HIV-TAT peptide forming Peptide 1 and its scramble arrangement in Peptide... by Deepu Dowarha (5673440)

Subjects:

Fig 9 - by Deepu Dowarha (5673440)

Subjects:

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Analysis of WST-1 assay. by Deepu Dowarha (5673440)

Subjects:

The ¹H−¹⁵N HSQC spectra overlay of free ¹⁵N p53 (1–73) (red) and in complex with unlabelled S100A1 (yellow). by Deepu Dowarha (5673440)

Subjects:

Fig 16 - by Deepu Dowarha (5673440)

Subjects:

Experimental workflow for isolation and characterization of vascular tissue-derived exosomes. by Ping-yu Cai (12389929)

Subjects:

S100A1 can interfere with the interaction between p53 and MDM2/MDMX. by Deepu Dowarha (5673440)

Subjects:

S100A1 interferes with the p53-MDM2 complex formation. by Deepu Dowarha (5673440)

Subjects:

S4 Minimal Data Set. Pzfx. by Ping-yu Cai (12389929)

Subjects:

Exploration of the connected interface (S100A1/MDM2) section in S100A1. by Deepu Dowarha (5673440)

Subjects:

Exploration of the connected interface (S100A1/MDM2) section in MDM2. by Deepu Dowarha (5673440)

Subjects:

Animation displaying S100A1−MDM2 complex generated via the HADDOCK program. by Deepu Dowarha (5673440)

Subjects:

Competitive binding experiment. by Deepu Dowarha (5673440)

Subjects:

The MCF-7 and/or MDA-MB-468 cells were treated with or without 10 μM Peptide 1 for 48h. by Deepu Dowarha (5673440)

Subjects: